Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

AbbVie Company Profile (NASDAQ:ABBV)

Consensus Ratings for AbbVie (NASDAQ:ABBV) (?)
Ratings Breakdown: 2 Hold Rating(s), 11 Buy Rating(s)
Consensus Rating:Buy (Score: 2.85)
Consensus Price Target: $63.92 (0.72% upside)

Current Analysts' Coverage Summary for AbbVie (NASDAQ:ABBV)
Show:
DateFirmActionRatingPrice TargetDetailsShare
10/23/2014JPMorgan Chase & Co.Initiated CoverageOverweight$67.00ViewTweet This Rating  Share This Rating on StockTwits
10/23/2014Goldman SachsInitiated CoverageBuy$68.00ViewTweet This Rating  Share This Rating on StockTwits
10/21/2014GuggenheimDowngradeBuy -> NeutralViewTweet This Rating  Share This Rating on StockTwits
10/17/2014Bank of AmericaReiterated RatingBuy$65.00 -> $61.00ViewTweet This Rating  Share This Rating on StockTwits
10/17/2014ISI GroupInitiated CoverageBuy$58.00ViewTweet This Rating  Share This Rating on StockTwits
10/16/2014BMO Capital MarketsLower Price TargetOutperform$71.00 -> $59.00ViewTweet This Rating  Share This Rating on StockTwits
9/15/2014ZacksReiterated RatingNeutral -> Neutral$61.00ViewTweet This Rating  Share This Rating on StockTwits
9/9/2014Cowen and CompanyBoost Price Target$62.00 -> $65.00ViewTweet This Rating  Share This Rating on StockTwits
8/6/2014Credit SuisseBoost Price TargetOutperform$60.00 -> $63.00ViewTweet This Rating  Share This Rating on StockTwits
7/14/2014Jefferies GroupReiterated RatingBuy$66.00 -> $71.00ViewTweet This Rating  Share This Rating on StockTwits
7/2/2014BarclaysUpgradeEqual Weight -> Overweight$44.00 -> $69.00ViewTweet This Rating  Share This Rating on StockTwits
6/24/2014ArgusBoost Price TargetBuy$59.00 -> $65.00ViewTweet This Rating  Share This Rating on StockTwits
6/2/2014Morgan StanleyReiterated RatingOverweight$60.00ViewTweet This Rating  Share This Rating on StockTwits
3/10/2014Ned Davis ResearchUpgradeNeutral -> BuyViewTweet This Rating  Share This Rating on StockTwits
7/29/2013Morgan JosephBoost Price TargetNeutral$41.00 -> $46.00ViewTweet This Rating  Share This Rating on StockTwits
5/15/2013R. F. LaffertyBoost Price TargetBuy$47.90 -> $61.00ViewTweet This Rating  Share This Rating on StockTwits
1/24/2013Hilliard LyonsDowngradeBuy -> NeutralViewTweet This Rating  Share This Rating on StockTwits
1/16/2013Wells Fargo & Co.Initiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
(Data available from 11/1/2012 forward)
Discuss AbbVie